Krilogy Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Krilogy Financial’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$4K	–	808
2018 Q3	$4K	Buy	+200	New	+$3.8K	﹤0.01%	665
2018 Q2	–	Sell	-400	Closed	-$6K	–	723
2018 Q1	$6K	Sell	400 -100	-20%	-$1.48K	﹤0.01%	591
2017 Q4	$7K	Hold	500	–	–	﹤0.01%	568
2017 Q3	$6K	Buy	500 +100	+25%	+$1.27K	﹤0.01%	638
2017 Q2	$5K	Hold	400	–	–	﹤0.01%	601
2017 Q1	$6K	Hold	400	–	–	﹤0.01%	570
2016 Q4	$6K	Buy	+400	New	+$7.25K	﹤0.01%	570
2016 Q2	–	Sell	-1,700	Closed	-$28K	–	775
2016 Q1	$28K	Hold	1,700	–	–	0.01%	350
2015 Q4	$37K	Sell	1,700 -700	-29%	-$13.6K	0.03%	161
2015 Q3	$48K	Buy	+2,400	New	+$75.8K	0.02%	211

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Krilogy Financial's HZNP Position: Q4 2018 in Review

Krilogy Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2018, closing a stake of 200 shares — an estimated $4K sold.

Krilogy Financial first reported a position in HZNP in Q3 2015 and held it in 10 quarters. The position peaked at $48K in Q3 2015. 239 funds tracked by Wall St. Rank hold HZNP as of Q4 2018.

Krilogy Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 200 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2018, an estimated $4K.
Krilogy Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 10 quarters.
Krilogy Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $48K in Q3 2015.
239 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.